NERLYNX
Identification of Nerlynx
| No description |
Google image searchProduct monograph
Active ingredient
neratinib (neratinib maleate), 40 MG
DIN: 02490536
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: KNIGHT THERAPEUTICS INC.
Date: 20-DEC-2019
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
- L01EH — Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors (ATC, ATC/DDD)
- L01EH02 — NERATINIB (ATC/DDD)
Reference brand drug: Nerlynx
